Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0367320120230030103
Journal of the Korean Academy of Child and Adolescent Psychiatry
2012 Volume.23 No. 3 p.103 ~ p.108
Change of Quality of Life in Children with ADHD after 12 Weeks OROS-Methylphenidate Treatment
Kim Hyung-In

Kim Bung-Nyun
Cho Soo-Churl
Shin Min-Sup
Yoo Hee-Jeong
Kim Jae-Won
Kim Ji-Hoon
Son Jung-Woo
Shin Yun-Mi
Chung Un-Sun
Han Doug-Hyun
Abstract
Objectives : The aim of this study is to investigate the effectiveness of treatment with osmotic-release oral system methylphenidate (OROS-MPH) on quality of life (QOL) in children with attention-deficit hyperactivity disorder (ADHD). Another aim is to assess the relationship between change in QOL and other factors including children¡¯s symptoms and academic performance or parents¡¯ depression and parenting stress.

Methods : A total of 111 medication-naive children with ADHD in a multicenter, open-label, 12-week trial of OROS-MPH completed an evaluation using diverse rating scales at two time points; at baseline and after 12 weeks of treatment. Scales for investigation of children included the Parent Report Form-Children¡¯s Health and Illness Profile-Children¡¯s Edition (PRF-CHIP-CE) on QOL, the ADHD Rating Scale-IV on symptoms, and the Academic Performance Rating Scale (APRS). The Beck Depression Inventory and Parenting Stress Index were used for assessment of their parents.

Results : Total scores for mean PRF-CHIP-CE increased from at baseline to after 12 weeks of treatment (p<.001). The change of APRS showed the strongest correlation with the increment of PRF-CHIP-CE scores (Pearson coefficient=0.561, p<.001), even after controlling for other factors (partial correlation coefficient=0.420, p<.001).

Conclusion : Treatment with MPH-OROS results in improvement of QOL in children with ADHD in Korea. The advance in academic performance plays a key role in this change of QOL.
KEYWORD
Quality of Life, Methylphenidate, Attention-Deficit Hyperactivity Disorder
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø